search
Back to results

Evaluation of the Physiodoloris Pain Monitor in Patients With Complex Regional Pain Syndrome (ANI-ALGO)

Primary Purpose

Complex Regional Pain Syndrome

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Ropivacaine 0.5%
Sponsored by
Hopital Foch
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Complex Regional Pain Syndrome

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients suffering from a Complex Regional Pain Syndrome of the upper or lower limb

Exclusion Criteria:

  • contra-indication of a nerve block,
  • contra-indication of the use of the pain monitor

Sites / Locations

  • Clinique des 2 Caps

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Perineural block

Arm Description

Perineural block with Ropivacaine 0.5%

Outcomes

Primary Outcome Measures

Evaluation of ANI before the peri-neural block
ANI is recorded before each nerve block
Evaluation of pain before the peri-neural block
Pain score is recorded before each nerve block

Secondary Outcome Measures

Evaluation of ANI after the peri-neural block
ANI is recorded after each nerve block
Evaluation of pain after the peri-neural block
Pain score is recorded after each nerve block

Full Information

First Posted
September 29, 2015
Last Updated
November 2, 2016
Sponsor
Hopital Foch
search

1. Study Identification

Unique Protocol Identification Number
NCT02663284
Brief Title
Evaluation of the Physiodoloris Pain Monitor in Patients With Complex Regional Pain Syndrome
Acronym
ANI-ALGO
Official Title
Evaluation of Non-invasive Monitor of Physiodoloris Pain in Patients With Complex Regional Pain Syndrome Treated by Nerve Block (Prospective Monocenter Study)
Study Type
Interventional

2. Study Status

Record Verification Date
November 2016
Overall Recruitment Status
Completed
Study Start Date
April 2012 (undefined)
Primary Completion Date
March 2014 (Actual)
Study Completion Date
March 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hopital Foch

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
A French University team (M. Jeanne, MD, and M. LOGIER, Ph D) have developed a pain assessment tool based on the analysis of the variability heart rate which evaluates the Analgesia Nociception Index (ANI). This index is intended to give a quantification of pain. The aim of the present study is to assess the validity of the ANI parameter in patients with Complex Regional Pain Syndrome treated with a nerve block (reversible pain).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Complex Regional Pain Syndrome

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Perineural block
Arm Type
Experimental
Arm Description
Perineural block with Ropivacaine 0.5%
Intervention Type
Drug
Intervention Name(s)
Ropivacaine 0.5%
Intervention Description
Ropivacaine is used to performed the perineural block
Primary Outcome Measure Information:
Title
Evaluation of ANI before the peri-neural block
Description
ANI is recorded before each nerve block
Time Frame
5 minutes
Title
Evaluation of pain before the peri-neural block
Description
Pain score is recorded before each nerve block
Time Frame
5 minutes
Secondary Outcome Measure Information:
Title
Evaluation of ANI after the peri-neural block
Description
ANI is recorded after each nerve block
Time Frame
10 minutes
Title
Evaluation of pain after the peri-neural block
Description
Pain score is recorded after each nerve block
Time Frame
10 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients suffering from a Complex Regional Pain Syndrome of the upper or lower limb Exclusion Criteria: contra-indication of a nerve block, contra-indication of the use of the pain monitor
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marc Fischler
Organizational Affiliation
Hopital Foch
Official's Role
Study Chair
Facility Information:
Facility Name
Clinique des 2 Caps
City
Coquelles
ZIP/Postal Code
62231
Country
France

12. IPD Sharing Statement

Learn more about this trial

Evaluation of the Physiodoloris Pain Monitor in Patients With Complex Regional Pain Syndrome

We'll reach out to this number within 24 hrs